PKTX
ProtoKinetix, Inc.Company Information
- Company Name
- ProtoKinetix, Inc.
- CIK
- CIK0001128189
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PKTX: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PKTX
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-09-26
- Last sale
- —
- Shares purchased (TTM)
- 14,953,334
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2024-06-30
- Institutional shares owned
- 70,600
- Shares outstanding
- 353,972,460
- Ownership
- 0.02%
Earnings Market Reaction
- Filing date
- 2026-09-03
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash Equivalents At Carrying Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 49 | 49 | 49 | 49 | 49 | 49 | 48 | 48 | 48 | 48 | 48 | 48 | ||||||
| Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -49 | -49 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 407 | 390 | 389 | 385 | 372 | 367 | 361 | 350 | 346 | 339 | 336 | 327 | ||||||
| Shares Outstanding | 407 | 390 | 389 | 385 | 372 | 367 | 361 | 350 | 346 | 339 | 336 | 327 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialProtoKinetix, Inc. (PKTX) — SEC Financial Statements & Analysis
ProtoKinetix, Inc. (PKTX) is a pharmaceutical preparations company, incorporated in NV. ProtoKinetix, Inc. trades on None as: PKTX. ProtoKinetix, Inc. (PKTX)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-09-03. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), ProtoKinetix, Inc. carries a market cap of $2.32M, a P/E ratio of -5.89x, a P/B ratio of 7.78x, an enterprise value of $2.32M, and an EV/EBITDA multiple of -6.77x. On profitability, it posts a Return on Equity (ROE) of -123.01%, a Return on Assets (ROA) of -80.45%, and a Return on Invested Capital (ROIC) of -124.14%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 8.09% year-over-year and EPS growth of 0.33% year-over-year. On the balance sheet, it maintains a current ratio of 0.08x, a quick ratio of 0.06x, working capital of $-81.01K, a debt-to-equity ratio of 0.62x, a debt ratio of 0.18, free cash flow of $-191.69K (TTM), and net debt of $-1.12K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.32M
- P/E TTM
- -5.89x
- EPS TTM
- $-0.00
- P/B TTM
- 7.78x
- ROE TTM
- -123.01%
- ROA TTM
- -80.45%
- Debt To Equity
- 0.62x
- Free Cash Flow TTM
- $-191.69K
Data as of 2025-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ProtoKinetix, Inc. in?
ProtoKinetix, Inc. (PKTX) operates in the Pharmaceutical Preparations industry.
What exchange does PKTX trade on?
ProtoKinetix, Inc. (PKTX) trades on the None.
Where is ProtoKinetix, Inc. incorporated?
ProtoKinetix, Inc. is incorporated in NV.
When was ProtoKinetix, Inc. (PKTX)'s most recent SEC filing?
ProtoKinetix, Inc. (PKTX)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-09-03.
What is PKTX's market cap?
ProtoKinetix, Inc. (PKTX) has a market capitalization of $2.32M as of 2025-12-31.
What is PKTX's EPS (earnings per share)?
ProtoKinetix, Inc. (PKTX)'s trailing twelve month EPS is $-0.00 as of 2025-12-31.
What is PKTX's ROE (return on equity)?
ProtoKinetix, Inc. (PKTX)'s trailing twelve month Return on Equity (ROE) is -123.01% as of 2025-12-31.
What is PKTX's ROA (return on assets)?
ProtoKinetix, Inc. (PKTX)'s trailing twelve month Return on Assets (ROA) is -80.45% as of 2024-09-30.
What is PKTX's ROIC (return on invested capital)?
ProtoKinetix, Inc. (PKTX)'s trailing twelve month Return on Invested Capital (ROIC) is -124.14% as of 2025-12-31.
What is PKTX's EV/EBITDA?
ProtoKinetix, Inc. (PKTX)'s trailing twelve month EV/EBITDA is -6.77x as of 2025-12-31.